+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

China - Healthcare, Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 159 Pages
  • March 2021
  • Region: China
  • GlobalData
  • ID: 2624361
Description Jump to:
China - Healthcare, Regulatory and Reimbursement Landscape

Summary

The publisher, the industry analysis specialist, has released its latest report “China - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Chinese pharmaceutical industry was valued at $72.1B in 2012 and grew to $134.6B in 2018. It is expected to reach $300.9B by 2025 at a Compound Annual Growth Rate (CAGR) of 12.2%. The increasing elderly population, expanding social health insurance, and regulatory reforms aimed at innovation and minimizing approval timelines are some of the factors driving the growth of the Chinese pharmaceutical market. China’s medical devices market was valued at $28.66B in 2015, which increased to $35.26B in 2019 at a CAGR of 5.36%. It is expected to grow at a CAGR of 5.90% from 2021 to reach $49.40B in 2025. The China’s 14th Five-Year Plan (2021–2025) and the Made in China (MIC) 2025 initiative are intended to strengthen innovation, develop an efficient domestic supply chain, and transform China into a “manufacturing superpower”.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in China, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sinopharm, Jiangsu Hengrui Medicine, and Beijing Tong Ren Tang
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, Boston Scientific, and Shinva
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Chinese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving China’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact China’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1. Table of Contents
1.1List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts about the Chinese Healthcare Market
2.3 Key Highlights: Healthcare Startups in China
2.4 Key Events: Chinese Healthcare Timeline, 2015–2021
2.5 Key Events: Facts About the Chinese Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019–2020
2.7 Key Events: Top Completed Deals by Value, 2019–2020
2.8 Country Profile, China, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market – Overview
3.2 Pharmaceutical Market – Exports
3.3 Pharmaceutical Market – Imports
3.4 Pharmaceutical Market – Supply Channels, China
3.5 Pharmaceutical Market – Market Segments
3.6 Pharmaceutical Market – Market Segment, Generics, China
3.7 Pharmaceutical Market – Market Segment, Biologics and Biosimilars, China
3.8 Pharmaceutical Market – Market Segment, Over-the-Counter Medicines, China
3.9 Pharmaceutical Market – Market Segment, Traditional Chinese Medicines, China
3.10 Pharmaceutical Market – Market Segment, Cell and Gene Therapy, China
3.11 COVID-19 Epidemiology, China
3.12 COVID-19 Impact and Developments in the Healthcare Market, China
3.13 COVID-19 Clinical Trials Landscape, China
3.14 Major Therapeutic Areas, China
3.15 Pharmaceutical Market – Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market – Overview
4.2 Medical Devices Market – Major Players
5. Pharmaceutical and Medical Devices Market – Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, China, 2020–2021
6.2Deal Analysis: Medical Devices Market, China, 2020–2021
7. HealthTech Landscape
7.1 HealthTech Deals Landscape, China
7.2 Key HealthTech Deals, China
7.3 Adoption of Technology in Healthcare, China
7.4 Regulatory Scenario Covering Use of Technology in Healthcare, China
7.5 HealthTech Landscape: Benefits and Risks, China
8. Market Access
8.1 Overview of Healthcare System, China
8.2 Reimbursement Process, China
8.3 Overview of Insurance Providers, China
8.4 Out-of-Pocket Spending and Consumer Price Index, China
8.5 Pricing Policies, China
8.6 Regulatory Landscape, China
8.6.1 Overview of Regulatory Agencies
8.7 Marketing Authorization for Pharmaceutical Products, China
8.8 Marketing Authorization for Generic Drugs, China
8.9 Market Authorization for Medical Devices, China
8.10 Intellectual Property Rights, Patent, China
8.11 Intellectual Property Rights, Trademark, China
8.12 Pharmaceutical Clinical Trials Landscape, China
8.13 Medical Devices Clinical Trials Landscape, China
8.14 Pharmaceutical Advertisement Regulations, China
8.15 Labeling and Packaging Regulations, China
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, China
9.2 Healthcare Facilities, China
9.3 Life Expectancy and Immunization Rate, China
9.4 Environmental Health, China
9.5 Healthcare Personnel, China
9.6 Disease Burden, China
9.7 Healthcare Expenditure, China
9.8 Pharmaceutical R&D Expenditure, China
10. Trade Associations, China11. Trade Fairs, China12. Opportunities and Challenges
13. Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer
List of Tables
Table 1: Domestic Companies Dominating Chinese Biosimilar Market, China, 2020
Table 2: NMPA-Approved New Drugs of Local Companies, China, 2020 (Jun’20-Dec’20)
Table 3: NMPA-Approved New Drugs of International Companies, China, 2020 (Aug’20-Dec’20)
Table 4: COVID-19 Indicators (Number of Cases), Global and China, 2020
Table 5: COVID-19 Marketed IVD Products (Oct ‘20 to Jan ‘21), China, 2021
Table 6: COVID-19 IVD Pipeline Products (In Approval Process), China, 2021
Table 7: Top Ten Therapeutic Areas by Morbidity Rate (1/100,000), China, 2019
Table 8: Medical Device Market, China, Major Segments ($M), 2020
Table 9: In Vitro Diagnostics Market, China, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 10: General Surgery Market, China, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 11: Orthopedic Devices Market, China, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Cardiovascular Devices Market, China, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 13: Wound Care Management Market, China, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 14: Public Insurance Schemes, China, 2020
Table 15:Drug Classification System, China, 2020
Table 16: Medical Devices Classification, China, 2020
Table 17: Trademark Process Timeline, China, 2020
Table 18: Trade Fairs, China, 2020
List of Figures
Figure 1: Pharmaceutical Market, China, Revenue ($B), 2012–2020
Figure 2: Medical Devices Market, China, Revenue ($B), 2015–2020
Figure 3: Healthcare Startups in China, 2020
Figure 4: Number of Deals (2019–2020)
Figure 5: 2019–2020 Deal Overview by Region
Figure 6: Country Profile, China, 2020
Figure 7: Pharmaceutical Market, China, Revenue ($B), 2011–2018
Figure 8: Pharmaceutical Market, China, Revenue Forecast ($B), 2019–2025
Figure 9: Pharmaceutical Exports ($B), China, 2010–2019
Figure 10: Top Export Partners, China, 2019
Figure 11: Pharmaceutical Imports ($B), China, 2010–2019
Figure 12: Top Import Partners, China, 2019
Figure 13: Pharmaceutical Supply Channel, China, 2019
Figure 14: Pharmaceutical Drug Sales Channel, China, 2019
Figure 15: Supply Channel Prior to 2017, China, 2019
Figure 16: Two Invoice System, China, 2019
Figure 17: Approval of Category 1 Innovative Products, China, 2015-2019
Figure 18: OTC Market, China, Revenue ($B), 2011–2020
Figure 19: OTC Medicines Market, Major Categories ($B), China, 2020
Figure 20: OTC Medicines Market, Major Distribution Channels ($M), China, 2020
Figure 21: Traditional Medicines, Revenue ($B), China, 2011–2020
Figure 22: Traditional Medicines, Per Capita Expenditure ($), China, 2011–2020
Figure 23: COVID-19 (Cases), China, 2020
Figure 24: COVID-19 (Deaths), China, 2020
Figure 25: Timeline of Facts & Control Measures During COVID-19 Epidemic, China, Dec ‘19 – Feb ’20
Figure 26: NMPA-approved Drug Applications Amid COVID-19 Epidemic, China, Q1 2019-Q1 2020
Figure 27: NMPA-approved Drug Applications Amid COVID-19 Epidemic, China, 2020
Figure 28: COVID-19 Clinical Trials Count By Trial Status, China, 2020
Figure 29: COVID-19 Clinical Trials Count By Phase, China, 2020
Figure 30: Top Five COVID-19 Clinical Trials Sponsors By Count, China, 2020
Figure 31: Top Five Therapeutic Areas by Morbidity Rate (%), China, 2019
Figure 32: Medical Device Market, China, Revenue ($B), 2015–2020
Figure 33: Medical Device Market, China, Revenue Forecast ($B), 2021–2025
Figure 34: Medical Device Market, China, Major Segments (%), 2020
Figure 35: In Vitro Diagnostics Market, China, Revenue ($B), 2017–2025
Figure 36: In Vitro Diagnostics Market, China, Market Share of Major Players (%), 2019
Figure 37: General Surgery Market, China, Revenue ($M), 2015–2022
Figure 38: General Surgery Market, China, Market Share of Major Players (%), 2019
Figure 39: Orthopedic Devices Market, China, Revenue ($B), 2017–2025
Figure 40: Orthopedic Devices Market, China, Market Share of Major Players (%), 2019
Figure 41: Cardiovascular Devices Market, China, Revenue ($B), 2017–2025
Figure 42: Cardiovascular Devices Market, China, Market Share of Major Players (%), 2019
Figure 43: Wound Care Management Market, China, Revenue ($B), 2017–2025
Figure 44: Wound Care Management Market, China, Market Share of Major Players (%), 2019
Figure 45: Diagnostic Market, China, Revenue ($B), 2015–2020
Figure 46: Diagnostic Market, China, Revenue ($B), 2021–2025
Figure 47: Medical Devices Market, Revenue ($B) of Major Companies, China, 2019
Figure 48: Deal Value and Deal Count, Pharmaceutical Market, China, 2020–2021
Figure 49: Deal Value and Deal Count Sub-types, Pharmaceutical Market, China, 2020–2021
Figure 50: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, China, 2020–2021
Figure 51: Top Five Therapy Areas by Deal Value ($M), Pharmaceutical Market, China, 2020–2021
Figure 52: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, China, 2020–2021

Related Topics

Related Reports

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 275 Pages
  • Global
From
Global Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Forecast to 2028 - Product Image

Global Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Forecast to 2028

  • Report
  • 320 Pages
  • Global
From
Global Revenue Cycle Management Market Report and Forecast 2023-2031 - Product Image

Global Revenue Cycle Management Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Healthcare Reimbursement Global Market Report 2024 - Product Image

Healthcare Reimbursement Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Image

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • 151 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.